Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Molecular and Cellular Endocrinology|June 19, 2017
Bromodomain-containing proteins in prostate cancerAlfonso Urbanucci, Ian G Mills
Molecular and Cellular Endocrinology|January 17, 2012
Androgen receptor (AR) aberrations in castration-resistant prostate cancerKati K Waltering, Alfonso Urbanucci, Tapio Visakorpi
The Prostate|January 4, 2012
Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structureAlfonso Urbanucci, Saara Marttila, Olli A Jänne, et al.
Endocrine-Related Cancer|February 6, 2014
Androgen-regulated metabolism and biosynthesis in prostate cancerStefan J Barfeld, Harri M Itkonen, Alfonso Urbanucci, et al.
Medical Oncology (Northwood, London, England)|July 22, 2025
Combination of PSMA targeting alpha-emitting radioligand [212Pb]Pb-AB001 with BET bromodomain inhibitors in in vitro prostate cancer modelsRugile Liukaityte, Vilde Yuli Stenberg, Andrius Kleinauskas, et al.
BMC Cancer|August 5, 2008
Androgen regulation of the androgen receptor coregulatorsAlfonso Urbanucci, Kati K Waltering, Hanna E Suikki, et al.
BMC Genomics|April 1, 2017
Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancerVerena Zuber, Francesco Bettella, Aree Witoelar, et al.
The Prostate|January 9, 2024
Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS)Dana Cavanaugh, Alfonso Urbanucci, Nihal E Mohamed, et al.
Plos One|April 11, 2015
Slug-dependent upregulation of L1CAM is responsible for the increased invasion potential of pancreatic cancer cells following long-term 5-FU treatmentKaja Lund, Jennifer L Dembinski, Nina Solberg, et al.
Cancers|July 20, 2021
Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic ResponseKonsta Kukkonen, Sinja Taavitsainen, Laura Huhtala, et al.
Pageof 5